Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02476032 · ClinicalTrials.gov registry record · NA
An Evaluation of the Efficacy of Oral-B New Product Sensi-Stop on Dentinal Hypersensitivity
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT02476032 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 60 participants.
The verdict
NCT02476032, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the efficacy of Sensi-StopTM strips (Procter \& Gamble™) on the relief of dentinal hypersensitivity. In other words, do Sensi-StopTM strips (Procter \& Gamble™) reduce or eliminate cold sensitivity in teeth? In addition, the investigators will evaluate whether there is a difference in the Sensi-StopTM strip (Procter \& Gamble™) effectiveness when the product is placed by a dental professional compared to self-placement by the person with sensitive teeth. This product is not experimental.
Interventions
- DEVICE Prof applied oxalate
- DEVICE Self applied oxalate
- DEVICE Prof applied placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2015-07 |
| Est. Completion | 2016-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02476032
The ClinicalTrials.gov registry entry for NCT02476032 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Prof applied oxalate is the first listed.
NCT02476032 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02476032 about?
NCT02476032 is a clinical study titled "An Evaluation of the Efficacy of Oral-B New Product Sensi-Stop on Dentinal Hypersensitivity". The purpose of the study is to evaluate the efficacy of Sensi-StopTM strips (Procter \& Gamble™) on the relief of dentinal hypersensitivity. In other words, do Sensi-StopTM strips (Procter \& Gamble™) reduce or eliminate cold sensitivity in teeth? In addition, the investigators will evaluate whether...
What is the current status of trial NCT02476032?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2015-07. Estimated completion is 2016-05.
What interventions are being tested in trial NCT02476032?
The interventions under investigation include: Prof applied oxalate (DEVICE), Self applied oxalate (DEVICE), Prof applied placebo (DEVICE).
Who is sponsoring clinical trial NCT02476032?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.